• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

P-100治疗梅尼埃病的临床研究

P-100 in the treatment of Ménière's disease: a clinical study.

作者信息

Franz Burkhard, van der Laan Frits

机构信息

Tinnitus Research and Balance Clinic, Wantirna, Australia.

出版信息

Int Tinnitus J. 2005;11(2):146-9.

PMID:16639914
Abstract

Patients suffering from Ménière's disease are particularly sensitive to negative pressure in the middle ear. For example, attacks of vertigo can be triggered by a descent in an aircraft when ventilation of the middle ear can become critical. Positive-pressure pulse treatment has been shown to have a beneficial effect on the symptomatology and is now a true alternative in the treatment of Ménière's disease. In this study, we compared two devices that produced positive-pressure pulses delivered to the inner ear via the external ear canal and after the insertion of a middle-ear ventilation tube. Both devices (Meniett and P-100) were equally successful and confirmed that positive-pressure pulse treatment is a true alternative to current treatment modalities. However, the P-100 is the preferred device, particularly for its convenience of use and its cost, which is considerably lower.

摘要

患有梅尼埃病的患者对中耳负压特别敏感。例如,乘坐飞机下降时,中耳通气可能变得至关重要,此时可能引发眩晕发作。正压脉冲治疗已被证明对症状有有益影响,现在是梅尼埃病治疗中的一种真正替代方法。在本研究中,我们比较了两种通过外耳道以及插入中耳通气管后向内耳输送正压脉冲的装置。两种装置(Meniett和P - 100)都同样成功,并证实正压脉冲治疗是当前治疗方式的一种真正替代方法。然而,P - 100是首选装置,特别是因其使用方便且成本低得多。

相似文献

1
P-100 in the treatment of Ménière's disease: a clinical study.P-100治疗梅尼埃病的临床研究
Int Tinnitus J. 2005;11(2):146-9.
2
[Local overpressure treatment reduces vestibular symptoms in patients with Menière's disease--secondary publication. A clinically randomised multicenter double-blind placebo-controlled study].[局部超压治疗可减轻梅尼埃病患者的前庭症状——二次发表。一项临床随机多中心双盲安慰剂对照研究]
Ugeskr Laeger. 2006 Jan 23;168(4):378-80.
3
Local pressure protocol, including Meniett, in the treatment of Ménière's disease: short-term results during the active stage.包括梅尼埃特疗法在内的局部加压方案治疗梅尼埃病:活动期短期疗效
Acta Otolaryngol. 2001 Dec;121(8):939-44.
4
Immediate effects of middle ear pressure changes on the electrocochleographic recordings in patients with Menière's disease: a clinical placebo-controlled study.
Am J Otol. 1997 Nov;18(6):726-33.
5
Intermittent pressure therapy of intractable Ménière's disease using the Meniett device: a preliminary report.使用梅尼埃特装置对难治性梅尼埃病进行间歇性压力治疗:初步报告。
Laryngoscope. 2002 Aug;112(8 Pt 1):1489-93. doi: 10.1097/00005537-200208000-00029.
6
Treatment of Meniere's disease with the low-pressure pulse generator (Meniett device).使用低压脉冲发生器(美尼埃氏病治疗仪)治疗梅尼埃病。
Expert Rev Med Devices. 2005 Sep;2(5):533-7. doi: 10.1586/17434440.2.5.533.
7
The effects of transtympanic micropressure treatment in people with unilateral Meniere's disease.经鼓膜微压治疗对单侧梅尼埃病患者的影响。
Arch Otolaryngol Head Neck Surg. 2004 Jun;130(6):718-25. doi: 10.1001/archotol.130.6.718.
8
[Middle ear overpressure with Meniett in Menière disease: indications, results at short and middle terms in 53 cases].[梅尼埃病中使用梅尼埃治疗仪产生的中耳超压:53例患者的适应证、短期和中期结果]
Rev Laryngol Otol Rhinol (Bord). 2007;128(1-2):33-6.
9
The effect of the Meniett device in patients with Ménière's disease: long-term results.美尼埃氏病患者使用梅尼埃特装置的效果:长期结果
Otol Neurotol. 2008 Sep;29(6):868-74. doi: 10.1097/MAO.0b013e318182025a.
10
Local overpressure treatment reduces vestibular symptoms in patients with Meniere's disease: a clinical, randomized, multicenter, double-blind, placebo-controlled study.局部超压治疗可减轻梅尼埃病患者的前庭症状:一项临床、随机、多中心、双盲、安慰剂对照研究。
Otol Neurotol. 2005 Jan;26(1):68-73. doi: 10.1097/00129492-200501000-00012.

引用本文的文献

1
Positive pressure therapy for Ménière's disease or syndrome.梅尼埃病或综合征的正压治疗
Cochrane Database Syst Rev. 2015 Mar 10;2015(3):CD008419. doi: 10.1002/14651858.CD008419.pub2.